Term ended Nov 7, 2026 · Low confidence
20-year base term ended Nov 7, 2026
Held by AngioDynamics, Inc.
Filed Apr 18, 2016 as application 15/132,116 · Granted Jan 16, 2018
Base term, 20 years from filing
Today
Term ended Nov 7, 2026
2006
2026
Clock starts
Nov 7, 2006
Nov 7, 2006
Term ended
Nov 7, 2026
Nov 7, 2026
Granted
Jan 16, 2018
Jan 16, 2018
base term
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,731,049, US 9,744,269, US 9,789,229, to Nov 7, 2026. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 7, 2006, when application 11/557,369, the earliest non-provisional in its chain, was filed (this one was filed Apr 18, 2016); a parent in its chain could not be resolved (the next row) | Nov 7, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,731,049, US 9,744,269, US 9,789,229) | resolves to Nov 7, 2026, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Nov 7, 2026 | Low confidence |
This family
| US 8,317,773 | In force Oct 2028 | Oct 2028 |
| Application 12/046,926 | Abandoned not computed | not computed |
| Application 12/392,220 | Abandoned not computed | not computed |
| US 8,603,070 | In force Jul 2033 | Jul 2033 |
| US 8,876,797 | In force Jul 2033 | Jul 2033 |
| Application 14/151,267 | Abandoned not computed | not computed |
| US 9,731,049 | In force Oct 2033 | Oct 2033 |
| US 9,867,908 | this patent Nov 2026 | Nov 2026 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 8, 2016 Reel 40613, frame 49 | AngioDynamics, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Feb 14, 2017 Reel 41714, frame 922 | Lareau, Raymond; Bell, Benjamin | AngioDynamics, Inc. | Assignment of Assignor's Interest |
| Mar 13, 2017 Reel 41557, frame 847 | Lareau, Raymond; Bell, Benjamin | AngioDynamics, Inc. | Assignment of Assignor's Interest |
| Mar 11, 2019 Reel 48560, frame 916 | Santerre, J. Paul; Ho, Jeannette | Interface Biologics Inc. | Assignment of Assignor's Interest |
| Jun 5, 2019 Reel 49371, frame 657 | AngioDynamics, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Confirmatory Grant of Security Interest in United States Patents |
| Oct 10, 2019 Reel 50683, frame 425 | Interface Biologics, Inc. | Evonik Canada Inc. | Assignment of Assignor's Interest |
| Aug 31, 2022 Reel 61360, frame 668 | AngioDynamics, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Aug 31, 2022 Reel 61363, frame 446 | JPMorgan Chase Bank, N.A., as Administrative Agent | AngioDynamics, Inc. | Release of Security Interest |
| May 9, 2023 Reel 63579, frame 347 | Lareau, Raymond; Bell, Benjamin | AngioDynamics, Inc. | Assignment of Assignor's Interest |
| Jun 8, 2023 Reel 63940, frame 362 | JPMorgan Chase Bank, N.A., as Administrative Agent | AngioDynamics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,731,049, US 9,744,269, US 9,789,229, ends no earlier than this term, so it caps nothing.
Citations
8
later US patents cite this one
That is above the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.